๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Urokinase-type plasminogen activator and malignancy

โœ Scribed by M.J. Duffy


Book ID
119154318
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
996 KB
Volume
7
Category
Article
ISSN
0268-9499

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Expression of urokinase-type plasminogen
โœ Maria E. L. van der Burg; Sonja C. Henzen-Logmans; Els M. J. J. Berns; Wim L. J. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 620 KB

Elevated levels of expression of the urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 have shown to be related to poor prognosis in a variety of cancer types. In the present study, cytosolic levels of uPA and PAI-1 were determined with enzyme-linked immunosorbent assays in cytosols

Urokinase-type plasminogen activator
โœ Massimo P. Crippa ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 243 KB
Urokinase plasminogen activator and urok
โœ C. Duggan; T. Maguire; E. McDermott; N. O'Higgins; J. J. Fennelly; M. J. Duffy ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 385 KB ๐Ÿ‘ 1 views

Urokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA mediates its action while attached to a membrane-bound receptor (uPAR). In this investigation we show that uPAR levels correlate with uPA levels in human breast cancers. uPAR levels, however, d